scholarly article | Q13442814 |
P2093 | author name string | Jie Huang | |
Qin Lu | |||
Peng Wu | |||
Yaping Wang | |||
Yongjun Fang | |||
Xuejie Zhang | |||
Liucheng Rong | |||
Meiyun Kang | |||
P2860 | cites work | Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia | Q28246779 |
The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome | Q33698398 | ||
Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis | Q34278721 | ||
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia | Q34314927 | ||
Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia | Q34517395 | ||
Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells | Q35237519 | ||
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study | Q36091293 | ||
Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group | Q36407162 | ||
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia | Q36915159 | ||
Standing Surgery of the Neck and Thorax | Q37059552 | ||
Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States | Q37350788 | ||
A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children's Oncology Group | Q37471074 | ||
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study | Q39822035 | ||
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia | Q40961746 | ||
Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter | Q43723771 | ||
Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood | Q44461319 | ||
Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A. | Q46853420 | ||
Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies | Q46981044 | ||
Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial | Q47858978 | ||
Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients | Q57205366 | ||
Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia | Q58481864 | ||
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia | Q78102270 | ||
Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? | Q80323224 | ||
Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions | Q83203008 | ||
P433 | issue | 50 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
database | Q8513 | ||
P304 | page(s) | 83767-83774 | |
P577 | publication date | 2016-08-31 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database | |
P478 | volume | 7 |
Search more.